A clinical trial comparing tapering doses of buprenorphine with steady doses for chronic pain and coexistent opioid addiction

Journal of Addiction Medicine

Volumn 4, Issue 3, 2010, Pages 140-146

  Blondell, Richard D ^a,b   Ashrafioun, Lisham ^c   Dambra, Christina M ^c   Foschio, Elisa M ^c   Zielinski, Amy L ^c   Salcedo, Daniel M ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b ERIE COUNTY MEDICAL CENTER   (United States)

^c NONE

Author keywords

Addiction; Buprenorphine; Detoxification; Opioids; Pain

Indexed keywords

EID: 78649232882     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3181ba895d     Document Type: Article

References (22)

1. Altier N, Dion D, Boulanger A, et al. Management of chronic neuropathic pain with methadone: A review of 13 cases. Clin J Pain 2005;21:364-369.
2. American Psychiatric Association. Diagnosis and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
3. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: A review of the evidence. Clin J Pain 2008;24:469-478.
4. Bridge TP, Fudala PJ, Herbert S, et al. Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence. Drug Alcohol Depend 2003;70(suppl 2):S79-S85.
5. Fingerhood AI. Illicit and therapeutic use of drugs with abuse liability. In: Barker LR, Burton JR, Zieve PD, eds. Principles of Ambulatory Medicine. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 1999: 264-286.
6. Heel RC, Brogden RN, Speight TM, et al. Buprenorphine: A review of its pharmacological properties and therapeutic efficacy. Drugs 1979;17: 81-110.
7. Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage 2004;27:260-267.
8. Johnson RE, Fudala PJ, Payne R. Buprenorphine: Considerations for pain management. J Pain Symptom Manage 2005 29:297-326.
9. Joranson DE, Leitman R. The McNeil National Pain Study. New York: Louis Harris and Associates, 1994.
10. Kakko J, Svanborg KD, Kreek MJ, et al. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial. Lancet 2003 361:662-668.
11. Karjalainen KA, Malmivaara A, van Tulder M, et al. Multidisciplinary biopsychosocial rehabilitation for subacute low-back pain among working age adults. Cochrane Database Syst Rev Available at http://www.cochrame.org/reviews/ en/ab002193.html. Accessed October 2, 2009.
12. Kennedy JA, Crowley TJ. Chronic pain and substance abuse: A pilot study of opioid maintenance. J Subst Abuse Treat 1990 7:233-238.
13. Malinoff HL, Barkin RL, Wilson G. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther 2005;12:379-384.
14. Manchikanti L, Brown KR, Singh V. National All Schedules Prescription Electronic Reporting Act (NASPER): Balancing substance abuse and medical necessity. Pain Physician 2002;5:294-319.
15. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146:116-127.
16. Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain 1999;80:1-13.
17. Rhodin A, Gronbladh L, Nilsson LH, et al. Methadone treatment of chronic non-malignant pain and opioid dependence - A long-term follow-up. Eur J Pain 2006;10:271-278.
18. Savage SR. Opioid medications in the management of pain. In: Graham AW, Schultz TK, Mayo-Smith MF, eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase, MD: American Society of Addiction Medicine, 2003:1451-1463.
19. Tennant FS Jr, Rawson RA. Outpatient treatment of prescription opioid dependence: Comparison of two methods. Arch Intern Med 1982;142: 1845-1847.
20. Torrington M, Domier CP, Hillhouse M, et al. Buprenorphine 101: Treating opioid dependence with buprenorphine in an office-based setting. J Addict Dis 2007;26:93-99.
21. Turk DC, Okifuji A, Kaluaokalani D. Clinical outcome and economic evaluation of multidisciplinary pain centers. In: Block AR, Kremer EF, Fernandez E, eds. Handbook of Pain Syndromes: Biopsychosocial Perspectives. Mahwah, NJ: Erlbaum, 1999.
22. Veterans Health Administration, Department of Defense. VA/DoD clinical practice guideline for the management of opioid therapy for chronic pain. Washington, DC: Veterans Health Administration, Department of Defense, 2003. Available at: http://www.guideline.gov/summary/summary.aspx?ss=15&doc-id= 4812&nbr=003474&string=chronic+AND+pain. Accessed April 24, 2009.